Subscribe
Business

Canada approves Merck grass allergy immunotherapy

By The Associated Press
Published
Add Washington Examiner on Google

WHITEHOUSE STATION, N.J. (AP) — Merck & Co. says it’s won its first approval for its new immunotherapy tablet for grass allergies, from regulators in Canada.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.